Asensus Surgical, Inc.

Equities

ASXC

US04367G1031

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.23 USD -1.71% Intraday chart for Asensus Surgical, Inc. -17.86% -27.88%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Asensus Surgical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Asensus Surgical, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Earnings Flash (ASXC) ASENSUS SURGICAL Reports Q4 Revenue $5.4M, vs. Street Est of $5.5M MT
Asensus Surgical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Investors -2- DJ
Transcript : Asensus Surgical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM
Asensus Surgical Preliminary Q4 Revenue Tops Estimates; Shares Rise MT
Asensus Surgical, Inc. Provides Unaudited Earnings Guidance for the Quarter and Full Year Ending on December 31, 2023 CI
Asensus Surgical, Inc. Develops the LUNA Surgical System CI
Cantor Fitzgerald Downgrades Asensus Surgical to Neutral From Overweight MT
Transcript : Asensus Surgical, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (ASXC) ASENSUS SURGICAL Posts Q3 Revenue $1.1M MT
Asensus Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Asensus Surgical Sells Senhance Surgical System to Distribution Partner MT
Certain Restricted Stock Units of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Certain Warrants of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Certain Options of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Certain Common Stock of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Transcript : Asensus Surgical, Inc., Q2 2023 Earnings Call, Aug 10, 2023
Earnings Flash (ASXC) ASENSUS SURGICAL Reports Q2 Revenue $1.1M, vs. Street Est of $1.07M MT
Asensus Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Asensus Surgical, Inc. Enters into Memorandum of Understanding with Karl Storz Ventureone Pte. Ltd CI
Asensus Surgical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Asensus Surgical, Inc., Q1 2023 Earnings Call, May 11, 2023
Asensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program CI
Chart Asensus Surgical, Inc.
More charts
Asensus Surgical, Inc. is a medical device company. The Company is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The Company is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.23 USD
Average target price
2 USD
Spread / Average Target
+769.57%
Consensus
  1. Stock
  2. Equities
  3. Stock Asensus Surgical, Inc. - Nyse
  4. News Asensus Surgical, Inc.
  5. Asensus Surgical : HC Wainwright Starts Asensus Surgical at Buy With $4 Price Target